Arine Medication Intelligence

Arine focuses relentlessly on improving health outcomes through medication optimization, delivering proven results. The platform helps health plans and at-risk provider organizations enhance care cost-effectively for diverse populations, including Medicare, Medicaid, Special Needs, and Commercial. Arine has demonstrated an impact on cost of care within six months and quality performance metrics in less than one year, having touched more than 30 million lives and produced over 40 million recommendations annually.

Arine leverages AI to understand the nuances of a population’s medication experiences within the context of their day-to-day lives, identifying care problems before they occur. This approach merges AI insights with deep clinical experience to deliver tailored medication recommendations, ensuring each member receives the right interventions at the right time. This is what Arine calls medication intelligence.

The platform’s approach integrates clinical, behavioral, and social data, including Social Determinants of Health (SDoH) factors, to understand patterns and anticipate issues. It uses AI algorithms to capture relevant care patterns and risk trajectories, leveraging AI-powered prioritization for efficient identification of opportunities to avert care problems. Clinical intelligence helps understand contextual complexities, craft accurate and compelling clinical recommendations, and tailor outreach to bridge cultural and language barriers. Medication intelligence delivers streamlined tools and clear guidance, maximizes effectiveness by combining information beyond human capacity, and fuels continuous improvement through feedback loops to hone patient targeting and intervention models.

Arine’s comprehensive medication management solutions deliver tailored, proactive interventions that alter risk trajectories, improving clinical outcomes and reducing costs of care across entire populations. This approach helps clients address the burden of medication mismanagement, which costs the U.S. approximately $528 billion annually.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist